Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
ReNew
RNW
$2.26B
| $887K | ﹤0.01% |
161,200
+35,200
| +28% | +$206K |
|
|
SSKN
2602
DELISTED
Strata Skin Sciences
SSKN
| $886K | ﹤0.01% |
112,165
-1,740
| -2% | -$14.9K |
|
|
TRT
2603
Trio-Tech International
TRT
$113M
| $886K | ﹤0.01% |
393,826
-44,200
| -10% | -$108K |
|
2604
Liquidia Corp
LQDA
$7.94B
| $884K | ﹤0.01% |
138,800
-125,488
| -47% | -$674K |
|
2605
A.O. Smith
AOS
$8.67B
| $881K | ﹤0.01% |
15,400
-95,700
| -86% | -$5.35M |
|
2606
Planet Fitness
PLNT
$3.98B
| $875K | ﹤0.01% |
11,100
-13,800
| -55% | -$963K |
|
2607
Rimini Street
RMNI
$470M
| $875K | ﹤0.01% |
229,730
-24,300
| -10% | -$108K |
|
|
DSEY
2608
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $875K | ﹤0.01% |
205,400
+96,600
| +89% | +$473K |
|
2609
Enliven Therapeutics
ELVN
$4.39B
| $874K | ﹤0.01% |
53,450
-28,881
| -35% | -$462K |
|
2610
IHS Holding
IHS
$2.81B
| $871K | ﹤0.01% |
141,600
-26,200
| -16% | -$163K |
|
2611
UTStarcom
UTSI
$23.7M
| $870K | ﹤0.01% |
245,162
-25,101
| -9% | -$101K |
|
2612
First Trust Capital Strength ETF
FTCS
$7.93B
| $869K | ﹤0.01% |
+11,600
| New | +$856K |
|
2613
Treace Medical Concepts
TMCI
$297M
| $867K | ﹤0.01% |
37,700
-30,900
| -45% | -$711K |
|
2614
LGL Group
LGL
$47.5M
| $866K | ﹤0.01% |
213,834
-411,585
| -66% | -$1.91M |
|
2615
Praxis Precision Medicines
PRAX
$9.91B
| $866K | ﹤0.01% |
24,267
-5,674
| -19% | -$177K |
|
2616
IRIDEX
IRIX
$14.6M
| $865K | ﹤0.01% |
430,360
-22,700
| -5% | -$50.4K |
|
2617
Lightpath Technologies
LPTH
$782M
| $864K | ﹤0.01% |
708,000
-33,700
| -5% | -$38K |
|
2618
InnovAge Holding
INNV
$1.48B
| $863K | ﹤0.01% |
120,200
-2,400
| -2% | -$15.4K |
|
2619
Apyx Medical
APYX
$173M
| $862K | ﹤0.01% |
368,195
-59,900
| -14% | -$183K |
|
2620
ACM Research
ACMR
$5.73B
| $860K | ﹤0.01% |
+111,600
| New | +$946K |
|
|
SELF
2621
Global Self Storage
SELF
$58.5M
| $857K | ﹤0.01% |
175,700
+36,500
| +26% | +$187K |
|
|
USER
2622
DELISTED
UserTesting, Inc.
USER
| $856K | ﹤0.01% |
114,000
+84,693
| +289% | +$542K |
|
2623
Triumph Financial Inc
TFIN
$1.83B
| $855K | ﹤0.01% |
17,500
-7,400
| -30% | -$400K |
|
|
BNR
2624
Burning Rock Biotech
BNR
$92.9M
| $854K | ﹤0.01% |
37,950
-16,130
| -30% | -$368K |
|
|
HTBK
2625
DELISTED
Heritage Commerce
HTBK
| $854K | ﹤0.01% |
65,700
+10,100
| +18% | +$136K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.